A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Stopped Sponsor decision
Conditions
- Venous Thromboembolism
- Deep Venous Thrombosis
- Pulmonary Embolism
Interventions
- BIOLOGICAL: Abelacimab
- DRUG: Apixaban
Sponsor
Anthos Therapeutics, Inc.
Collaborators